IGC Pharma, Inc.
IGC
$0.32
$0.011.67%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.88% | -33.58% | 34.55% | -6.52% | 27.80% |
| Total Depreciation and Amortization | -15.60% | -8.44% | -1.91% | 8.28% | -10.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -175.93% | -29.72% | 59.84% | -1.80% | -3.48% |
| Change in Net Operating Assets | 83.29% | -27.36% | -1,038.46% | -113.83% | 203.23% |
| Cash from Operations | -48.54% | -92.74% | 44.57% | -32.23% | 43.15% |
| Capital Expenditure | -262.50% | 55.56% | 33.33% | 6.90% | 23.68% |
| Sale of Property, Plant, and Equipment | -103.28% | 2,825.00% | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -182.46% | 22.97% | -92.21% | -48.08% | 44.09% |
| Cash from Investing | -164.48% | 508.45% | -36.54% | -60.00% | 50.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | 100.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 265.14% | 5.84% | 132.66% | -56.48% | -68.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 265.45% | 5.71% | 133.33% | -56.55% | -68.33% |
| Foreign Exchange rate Adjustments | -80.00% | 1,150.00% | -- | 100.00% | -650.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,228.57% | 175.38% | 93.96% | -287.05% | -144.41% |